$197.28
-0.80%
Indicators
| Indicator | Value | Meaning |
|---|---|---|
| Quality rank | 98.2 | Cross-sectional percentile built by the pipeline |
| RSI 14 | 74.9 | Relative strength index over 14 days |
| SMA 20 | 158.66 | 20-day simple moving average |
| SMA 50 | 112.82 | 50-day simple moving average |
| EMA 20 | 160.91 | 20-day exponential moving average |
| ATR 14 | 12.69 | Average true range over 14 days |
| RVOL 20 | 0.87 | Volume relative to its own 20-day average |
Values are read from the stored feature table as of 2026-09-28, source yahoo. A dash means the pipeline has no value for that indicator; it is not replaced by an estimate.
Detected patterns
Gap down
2026-09-22
BEARISHStrength 26%
Volatility breakout
2026-09-21
BULLISHStrength 100%
Gap up
2026-09-21
BULLISHStrength 46%
Gap up
2026-09-17
BULLISHStrength 47%
Gap up
2026-09-04
BULLISHStrength 32%
Gap down
2026-09-03
BEARISHStrength 32%
A pattern is a description of stored prices, not a prediction. Crosses need more than 200 bars, so an instrument with a short history shows fewer of them.
Related news
Up Over 550% in 2026, Is It Too Late to Buy Moderna Stock?
Positive news surrounding its personalized cancer vaccine has lit a fire under the healthcare stock.
Yahoo2026-09-28Sentiment —
These S&P500 stocks that are showing activity before the opening bell on Monday.
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements.
ChartMill2026-09-28Sentiment —
Laidlaw analyst Yale Jen flagged possible data in other cancers from 2027, while warning that personalized manufacturing costs, capacity and reimbursement could limit commercial success.
Yahoo2026-09-28Sentiment —
Why Did AMD, HPE, MRNA Stocks Surge To 52-Week Highs Last Week?
Investors rewarded companies with strong artificial intelligence demand, enterprise infrastructure, and drug development.
Yahoo2026-09-28Sentiment —
Why Moderna (MRNA) Is Up 29.1% After Melanoma Vaccine Success And Middle East Expansion Talks
In recent weeks, Moderna and Merck reported that their Phase 3 INTerpath-001 trial of personalized cancer vaccine intismeran autogene plus Keytruda met its primary endpoint in melanoma, with full data presented earlier this month at the European Society for Medical Oncology Congress 2026 and accompanied by growing oncology-focused pipeline visibility. At the same time, Moderna’s talks with Middle East partners about potential investment and manufacturing cooperation highlight how its mRNA...
Yahoo2026-09-26Sentiment —
Moderna (MRNA) Held Investment Talks With The UAE Government
Moderna (NasdaqGS:MRNA) entered high-level investment talks with the UAE government on advanced pharmaceutical manufacturing and R&D collaboration. The discussions focus on expanded research capabilities, potential local production, and broader access to Middle Eastern healthcare markets. Management framed the UAE engagement as part of a wider push to build out Moderna's international footprint beyond existing Western partnerships. The UAE collaboration talks matter, but investors also need...
Yahoo2026-09-26Sentiment —
U.S. stocks advanced for the week while Treasury yields surged and petroleum markets remained in focus. Read more about this week's major events on Wall Street.
SeekingAlpha2026-09-26Sentiment —
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Moderna (MRNA) concluded the recent trading session at $198.88, signifying a +2.08% move from its prior day's close.
Yahoo2026-09-25Sentiment —